TEAS Plus New Application

ZYESAMI

NeuroRx, Inc.

Trademark/Service Mark Application, Principal Register

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

TEAS Plus Application

Serial Number: 90309552
Filing Date: 11/10/2020

NOTE: Data fields with the * are mandatory under TEAS Plus. The wording "(if applicable)" appears where the field is only mandatory under the facts of the particular application.


The table below presents the data as entered.

Input Field
Entered
TEAS Plus YES
MARK INFORMATION
*MARK ZyeSAMI
*STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT ZyeSAMI
*MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK NeuroRx, Inc.
*MAILING ADDRESS 1201 North Market Street - Suite 111
*CITY Wilmington
*STATE
(Required for U.S. applicants)
Delaware
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
19801
PHONE 202-340-1352
*EMAIL ADDRESS XXXX
WEBSITE ADDRESS www.neurorxpharma.com
LEGAL ENTITY INFORMATION
*TYPE CORPORATION
* STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
*INTERNATIONAL CLASS 005 
*IDENTIFICATION Pharmaceutical preparations, namely, antivirals; Pharmaceutical products for treating respiratory diseases
*FILING BASIS SECTION 1(b)
ADDITIONAL STATEMENTS INFORMATION
*TRANSLATION
(if applicable)
 
*TRANSLITERATION
(if applicable)
 
*CLAIMED PRIOR REGISTRATION
(if applicable)
 
*CONSENT (NAME/LIKENESS)
(if applicable)
 
*CONCURRENT USE CLAIM
(if applicable)
 
CORRESPONDENCE INFORMATION
NAME NeuroRx, Inc.
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE jjavitt@neurorxpharma.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) bdelbuono@neurorxpharma.com; adaigneault@neurorxpharma.com
FEE INFORMATION
APPLICATION FILING OPTION TEAS Plus
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 225
*TOTAL FEES DUE 225
*TOTAL FEES PAID 225
SIGNATURE INFORMATION
* SIGNATURE /Jonathan C. Javitt/
* SIGNATORY'S NAME Jonathan C. Javitt
* SIGNATORY'S POSITION CEO
SIGNATORY'S PHONE NUMBER 202-340-1352
* DATE SIGNED 11/10/2020



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)


Trademark/Service Mark Application, Principal Register

TEAS Plus Application

Serial Number: 90309552
Filing Date: 11/10/2020

To the Commissioner for Trademarks:

MARK: ZyeSAMI (Standard Characters, see mark)
The literal element of the mark consists of ZyeSAMI. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, NeuroRx, Inc., a corporation of Delaware, having an address of
      1201 North Market Street - Suite 111
      Wilmington, Delaware 19801
      United States
      202-340-1352(phone)
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

For specific filing basis information for each item, you must view the display within the Input Table.
International Class 005:  Pharmaceutical preparations, namely, antivirals; Pharmaceutical products for treating respiratory diseases
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services. (15 U.S.C. Section 1051(b)).


For informational purposes only, applicant's website address is: www.neurorxpharma.com
The applicant's current Correspondence Information:
      NeuroRx, Inc.
       PRIMARY EMAIL FOR CORRESPONDENCE: jjavitt@neurorxpharma.com
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): bdelbuono@neurorxpharma.com; adaigneault@neurorxpharma.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $225 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /Jonathan C. Javitt/   Date: 11/10/2020
Signatory's Name: Jonathan C. Javitt
Signatory's Position: CEO
Signatory's Phone Number: 202-340-1352
Payment Sale Number: 90309552
Payment Accounting Date: 11/10/2020

Serial Number: 90309552
Internet Transmission Date: Tue Nov 10 12:02:32 ET 2020
TEAS Stamp: USPTO/FTK-XX.XXX.XXX.XX-2020111012023256
3364-90309552-750d2dc7b27c94f2dcf239c71d
abe6232de33b5cc72c71e1b5c8d8ee9a1766586-
CC-02311334-20201110114635423244

TEAS Plus New Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed